Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

A Phase I Study of Pegylated Arginine Deiminase (Pegargiminase), Cisplatin, and Pemetrexed in Argininosuccinate Synthetase 1-Deficient Recurrent High-grade Glioma.

Hall PE, Lewis R, Syed N, Shaffer R, Evanson J, Ellis S, Williams M, Feng X, Johnston A, Thomson JA, Harris FP, Jena R, Matys T, Jefferies S, Smith K, Wu BW, Bomalaski JS, Crook T, O'Neill K, Paraskevopoulos D, Khadeir RS, Sheaff M, Pacey S, Plowman PN, Szlosarek PW.

Clin Cancer Res. 2019 May 1;25(9):2708-2716. doi: 10.1158/1078-0432.CCR-18-3729. Epub 2019 Feb 22.

PMID:
30796035
2.

The Potential in Preparing Community Health Workers to Address Hearing Loss.

Sánchez D, Adamovich S, Ingram M, Harris FP, de Zapien J, Sánchez A, Colina S, Marrone N.

J Am Acad Audiol. 2017 Jun;28(6):562-574. doi: 10.3766/jaaa.16045.

PMID:
28590899
3.

Interventional Audiology to Address Hearing Health Care Disparities: Oyendo Bien Pilot Study.

Marrone N, Ingram M, Somoza M, Jacob DS, Sanchez A, Adamovich S, Harris FP.

Semin Hear. 2017 May;38(2):198-211. doi: 10.1055/s-0037-1601575. Review.

4.

The Effects of FM and Hearing Aid Microphone Settings, FM Gain, and Ambient Noise Levels on SNR at the Tympanic Membrane.

Norrix LW, Camarota K, Harris FP, Dean J.

J Am Acad Audiol. 2016 Feb;27(2):117-25. doi: 10.3766/jaaa.15012.

PMID:
26905531
5.

Modeling the Influence of Acoustic Coupling of Hearing Aids on FM Signal-to-Noise Ratio.

Norrix LW, Van Tasell D, Ross J, Harris FP, Dean J.

Am J Audiol. 2015 Jun;24(2):178-87. doi: 10.1044/2015_AJA-14-0035.

PMID:
25651525
6.

High grade glioma--the arrival of the molecular diagnostic era for patients over the age of 65 years in the UK.

Jefferies SJ, Harris FP, Price SJ, Collins VP, Watts C.

Clin Oncol (R Coll Radiol). 2013 Jul;25(7):391-3. doi: 10.1016/j.clon.2013.03.005. Epub 2013 Apr 21. No abstract available.

PMID:
23615180
7.
8.

Effect of presentation modality on immediate and delayed recall in individuals with Alzheimer's disease.

Mahendra N, Bayles KA, Harris FP.

Am J Speech Lang Pathol. 2005 May;14(2):144-55.

PMID:
15989389
9.

Effect of release time on preferred gain and speech acoustics.

Muller TF, Harris FP, Ellison JC.

J Am Acad Audiol. 2004 Oct;15(9):605-15.

PMID:
15575335
10.

Interactions of hearing aid compression release time and fitting formula: effects on speech acoustics.

Ellison JC, Harris FP, Muller T.

J Am Acad Audiol. 2003;14(2):59-71. Erratum in: J Am Acad Audiol. 2003 Dec;14(10):592.

PMID:
12830842
11.

Otoacoustic emissions.

Probst R, Harris FP.

Adv Otorhinolaryngol. 1997;53:182-204. Review. No abstract available.

PMID:
9226052
12.

Two sources of acoustic distortion products from the human cochlea.

Brown AM, Harris FP, Beveridge HA.

J Acoust Soc Am. 1996 Nov;100(5):3260-7.

PMID:
8914308
13.
14.

Otoacoustic emissions: an approach for monitoring aminoglycoside-induced ototoxicity.

Hotz MA, Harris FP, Probst R.

Laryngoscope. 1994 Sep;104(9):1130-4.

PMID:
8072361
15.

Peripheral analysis of frequency in human ears revealed by tone burst evoked otoacoustic emissions.

Xu L, Probst R, Harris FP, Roede J.

Hear Res. 1994 Apr;74(1-2):173-80.

PMID:
8040086
17.

Repeatability of distortion product otoacoustic emissions in normally hearing humans.

Roede J, Harris FP, Probst R, Xu L.

Audiology. 1993 Sep-Oct;32(5):273-81.

PMID:
8216026
18.
19.

Monitoring the effects of noise exposure using transiently evoked otoacoustic emissions.

Hotz MA, Probst R, Harris FP, Hauser R.

Acta Otolaryngol. 1993 Jul;113(4):478-82.

PMID:
8379302
20.
21.

Clinical monitoring using otoacoustic emissions.

Probst R, Harris FP, Hauser R.

Br J Audiol. 1993 Apr;27(2):85-90.

PMID:
8220286
22.
23.

Suppression of the 2f1-f2 otoacoustic emission in humans.

Harris FP, Probst R, Xu L.

Hear Res. 1992 Dec;64(1):133-41. Erratum in: Hear Res 1993 Mar;66(1):121.

PMID:
1490896
24.

Influence of general anesthesia on transiently evoked otoacoustic emissions in humans.

Hauser R, Probst R, Harris FP, Frei F.

Ann Otol Rhinol Laryngol. 1992 Dec;101(12):994-9.

PMID:
1463300
25.

Transiently evoked otoacoustic emissions in patients with Menière's disease.

Harris FP, Probst R.

Acta Otolaryngol. 1992;112(1):36-44.

PMID:
1575035
26.
27.

[The clinical use of oto-acoustic emissions of cochlear distortion products].

Hauser R, Probst R, Harris FP.

Laryngorhinootologie. 1991 Mar;70(3):123-31. German.

PMID:
2036146
28.

Repeatability of transiently evoked otoacoustic emissions in normally hearing humans.

Harris FP, Probst R, Wenger R.

Audiology. 1991;30(3):135-41.

PMID:
1953443
29.

Objective measures of sentence level with respect to loudness.

Tschopp K, Beckenbauer T, Harris FP.

Audiology. 1991;30(2):113-22.

PMID:
1877898
30.
31.

Psychoacoustical and ear canal cancellation of (2f1-f2)-distortion products.

Zwicker E, Harris FP.

J Acoust Soc Am. 1990 Jun;87(6):2583-91.

PMID:
2373793
32.

Distortion product emissions in humans. III. Influence of sensorineural hearing loss.

Martin GK, Ohlms LA, Franklin DJ, Harris FP, Lonsbury-Martin BL.

Ann Otol Rhinol Laryngol Suppl. 1990 May;147:30-42.

PMID:
2110798
33.

Distortion product emissions in humans. I. Basic properties in normally hearing subjects.

Lonsbury-Martin BL, Harris FP, Stagner BB, Hawkins MD, Martin GK.

Ann Otol Rhinol Laryngol Suppl. 1990 May;147:3-14.

PMID:
2110797
34.

Distortion product emissions in humans. II. Relations to acoustic immittance and stimulus frequency and spontaneous otoacoustic emissions in normally hearing subjects.

Lonsbury-Martin BL, Harris FP, Stagner BB, Hawkins MD, Martin GK.

Ann Otol Rhinol Laryngol Suppl. 1990 May;147:15-29.

PMID:
2110796
35.

Acoustic distortion products in humans: systematic changes in amplitudes as a function of f2/f1 ratio.

Harris FP, Lonsbury-Martin BL, Stagner BB, Coats AC, Martin GK.

J Acoust Soc Am. 1989 Jan;85(1):220-9.

PMID:
2921404
36.

Use of hearing-aid-processed stimuli in hearing aid evaluation.

Harris FP, Hodgson WR.

Audiology. 1974;13(6):490-4. No abstract available.

PMID:
4416819

Supplemental Content

Loading ...
Support Center